MC4 THERAPY: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MC4 THERAPY
Largest movements
- Receivables after one year +€3,205
new in 2025: €3,205
- Tangible fixed assets -€1,862
down €1,862 (-41.1%), from €4,536 to €2,673
- Cash +€238
up €238 (+4.4%), from €5,471 to €5,709
mainly Net result for the year (+€3,772) and Depreciation (+€2,494)
- Profit (loss) carried forward +€3,772
up €3,772 (+57.1%), from €6,602 to €10,374
- Trade debts -€1,795
down €1,795 (-93.2%), from €1,926 to €131
- Other debts -€379
down €379 (-99.6%), from €380 to €2
- Gross operating margin +€10,875
up €10,875, from -€3,080 to €7,795
- Taxes +€498
up €498, from -€36 to €462
- Other operating charges +€477
up €477 (+76.7%), from €622 to €1,099
- Staff costs -€253
no longer reported in 2025 (was €253)
- Depreciation +€82
up €82 (+3.4%), from €2,413 to €2,494
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €11,407 | €13,068 | +€1,661 | +14.6% |
| Fixed assets | 21/28 | €4,536 | €2,673 | -€1,862 | -41.1% |
| Tangible fixed assets | 22/27 | €4,536 | €2,673 | -€1,862 | -41.1% |
| Furniture and vehicles | 24 | €4,536 | €2,673 | -€1,862 | -41.1% |
| Current assets | 29/58 | €6,871 | €10,394 | +€3,523 | +51.3% |
| Amounts receivable after more than one year | 29 | - | €3,205 | +€3,205 | |
| Other amounts receivable | 291 | - | €3,205 | +€3,205 | |
| Amounts receivable within one year | 40/41 | €1,400 | €1,400 | = | 0.0% |
| Trade receivables | 40 | €1,400 | €1,400 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €5,471 | €5,709 | +€238 | +4.4% |
| Deferred charges and accrued income | 490/1 | - | €80 | +€80 | |
| Total equity and liabilities | 10/49 | €11,407 | €13,068 | +€1,661 | +14.6% |
| Equity | 10/15 | €8,602 | €12,374 | +€3,772 | +43.9% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €6,602 | €10,374 | +€3,772 | +57.1% |
| Amounts payable | 17/49 | €2,804 | €693 | -€2,111 | -75.3% |
| Amounts payable within one year | 42/48 | €2,804 | €693 | -€2,111 | -75.3% |
| Trade debts | 44 | €1,926 | €131 | -€1,795 | -93.2% |
| Suppliers | 440/4 | €1,926 | €131 | -€1,795 | -93.2% |
| Taxes, remuneration and social security | 45 | €499 | €561 | +€62 | +12.5% |
| Taxes | 450/3 | - | €462 | +€462 | |
| Remuneration and social security | 454/9 | €499 | €99 | -€400 | -80.2% |
| Other amounts payable | 47/48 | €380 | €2 | -€379 | -99.6% |
| Remuneration, social security and pensions | 62 | €253 | - | -€253 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,413 | €2,494 | +€82 | +3.4% |
| Other operating charges | 640/8 | €622 | €1,099 | +€477 | +76.7% |
| Gross operating margin | 9900 | -€3,080 | €7,795 | +€10,875 | |
| Operating profit (loss) | 9901 | -€6,368 | €4,202 | +€10,569 | |
| Financial income | 75/76B | - | €80 | +€80 | |
| Recurring financial income | 75 | - | €80 | +€80 | |
| Financial charges | 65/66B | €44 | €48 | +€4 | +8.7% |
| Recurring financial charges | 65 | €44 | €48 | +€4 | +8.7% |
| Profit (loss) for the period before taxes | 9903 | -€6,411 | €4,234 | +€10,646 | |
| Income taxes | 67/77 | -€36 | €462 | +€498 | |
| Profit (loss) for the period | 9904 | -€6,375 | €3,772 | +€10,148 | |
| Profit (loss) for the period to be appropriated | 9905 | -€6,375 | €3,772 | +€10,148 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 2 October 2026 via checked.be.